ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,000 | -96.7% | 31,691 | -95.1% | 0.00% | -100.0% |
| Q2 2020 | $478,000 | +159.8% | 651,136 | +230.8% | 0.00% | – |
| Q1 2020 | $184,000 | +327.9% | 196,866 | +839.8% | 0.00% | – |
| Q4 2019 | $43,000 | -66.9% | 20,948 | -54.0% | 0.00% | – |
| Q3 2019 | $130,000 | -69.0% | 45,535 | +43.9% | 0.00% | -100.0% |
| Q1 2019 | $420,000 | -96.5% | 31,634 | -95.9% | 0.00% | -94.7% |
| Q4 2018 | $11,893,000 | -21.2% | 763,337 | -0.6% | 0.02% | +5.6% |
| Q3 2018 | $15,090,000 | -19.4% | 767,918 | +17.8% | 0.02% | -25.0% |
| Q2 2018 | $18,714,000 | +7.7% | 652,064 | -11.3% | 0.02% | +4.3% |
| Q1 2018 | $17,377,000 | +307.5% | 734,774 | +269.6% | 0.02% | +283.3% |
| Q4 2017 | $4,264,000 | +8.7% | 198,804 | -0.2% | 0.01% | -14.3% |
| Q2 2017 | $3,924,000 | -12.1% | 199,203 | -6.3% | 0.01% | -12.5% |
| Q1 2017 | $4,463,000 | -58.1% | 212,538 | -62.5% | 0.01% | -63.6% |
| Q4 2016 | $10,650,000 | +105.8% | 566,464 | +128.5% | 0.02% | +144.4% |
| Q3 2016 | $5,176,000 | -64.1% | 247,871 | -56.2% | 0.01% | -72.7% |
| Q2 2016 | $14,429,000 | +6.4% | 565,729 | +10.3% | 0.03% | -2.9% |
| Q1 2016 | $13,566,000 | -52.1% | 512,895 | -22.5% | 0.03% | -42.4% |
| Q4 2015 | $28,323,000 | +27.4% | 662,064 | -21.1% | 0.06% | +37.2% |
| Q3 2015 | $22,236,000 | +61.4% | 838,769 | +102.9% | 0.04% | +65.4% |
| Q2 2015 | $13,780,000 | -51.2% | 413,441 | -51.3% | 0.03% | -50.9% |
| Q1 2015 | $28,258,000 | +308.4% | 849,084 | +401.5% | 0.05% | +253.3% |
| Q4 2014 | $6,920,000 | -28.0% | 169,313 | -40.3% | 0.02% | -37.5% |
| Q3 2014 | $9,614,000 | -59.6% | 283,759 | -59.8% | 0.02% | -63.6% |
| Q2 2014 | $23,784,000 | +226.2% | 705,560 | +182.5% | 0.07% | +187.0% |
| Q4 2013 | $7,292,000 | +125.0% | 249,723 | +163.5% | 0.02% | +130.0% |
| Q3 2013 | $3,241,000 | -23.3% | 94,770 | -26.0% | 0.01% | -23.1% |
| Q2 2013 | $4,226,000 | – | 128,090 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |